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may have filtered out other potentially harmful materi-
al, including emboli, particularly because the pump
times were long. Clinical studies have shown that with
hypothermic arrest, the pump time is a strong predictor
of stroke and neurocognitive deficit.
Should filtration therefore be used in the clinical
setting, particularly for cardiac operations requiring
prolonged CPB? This study, other animal studies, and
the randomized study from Emory would suggest that
there is a benefit to arterial leukocyte filtration,
although the Emory study failed to show a neurolog-
ic benefit. Ideally, a large clinically prospective ran-
domized study, including assessment of neurocogni-
tive function, should be done to answer the question
of benefit. The one potential drawback with leukocyte
filtration is that platelet levels are reduced, although
this can be prevented by prebypass plasma pheresis,
which is the method we use to reduce the loss of
platelets with filtration. Thus, since December 1993,
we have routinely used this same leukocyte-depletion
filter for patients undergoing ascending aorta or aor-
tic arch operations, including deep hypothermia and
circulatory arrest. In 276 such patients, the stroke rate
has been 2.9% (8/276; 30-day mortality, 1.8%
[5/275]). Although we do not have a concurrent com-
parative group, compared with historical patients, it is
our impression that postoperative cardiac dysfunc-
tion, pump lung, multiple organ failure, and neurolog-
ic injury have been reduced, particularly subtle forms,
including neurocognitive deficits. This is supported
by a recent prospective randomized study we did with
neurocognitive evaluation. Clearly, other factors have
also contributed to improved results. Nevertheless, we
endorse the more frequent use of arterial leukocyte
filtration for prolonged CPB times.
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Since the 1970s, leukocytes have been shown to play
a causative role in neurologic injury, particularly after
ischemia. Indeed, in the early 1980s, much research
effort was devoted to negating leukocyte-mediated
injury by the administration of superoxide dismutase to
combat free oxygen radicals, steroids to reduce inflam-
mation, and agents to prevent other harmful effects. In
our own research, trying to prevent spinal cord reperfu-
sion injury after aortic crossclamping, we tried super-
oxide dismutase and allopurinol. Our results showed
that the animals appeared to be more hemodynamically
stable, and stress ulceration in the stomach was absent,
but spinal neurologic injury was not prevented. More
recently, the Johns Hopkins University group and oth-
ers have shown that leukocyte filtration is effective in
reducing myocardial and pulmonary injury after
ischemia and also in reducing reperfusion injury in
transplanted organs.
In this study Rimpiläinen and colleagues present their
results after using a leukocyte filter during cardiopul-
monary bypass (CPB) in animals undergoing 75 minutes
of circulatory arrest. They found that filtration resulted
in a lower mortality rate, better behavioral recovery, and
less histologic evidence of brain injury. Although exclu-
sion of the early deaths in the control group did not
result in a significant difference in behavioral or histo-
logic scores, there nevertheless was a trend toward bet-
ter neurologic outcome for the filtered animals (behav-
ioral score, P = .08; histologic score, P = .08).
Although not discussed in the authors’ study, filtra-
tion may also have other benefits apart from leukocyte
removal, particularly because they noted little effect on
proinflammatory cytokines (ie, tumor necrosis factor α,
interleukin 1β, and interleukin 8). Microfiltration alone,
without leukocyte depletion, has been known to be ben-
eficial for a long period of time, and with increasing
evidence of microgaseous and particulate emboli affect-
ing postoperative neurocognitive function, the authors
